Cargando…
Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
Autores principales: | Gaetani, Eleonora, Passali, Giulio Cesare, Riccioni, Maria E., Tortora, Annalisa, Pola, Roberto, Costamagna, Guido, Gasbarrini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770823/ https://www.ncbi.nlm.nih.gov/pubmed/32348627 http://dx.doi.org/10.1111/jth.14885 |
Ejemplares similares
-
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group
por: Gaetani, Eleonora, et al.
Publicado: (2019) -
Beneficial Effects of Remote Medical Care for Patients with Hereditary Hemorrhagic Telangiectasia during the COVID-19 Pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2021) -
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020) -
Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928) -
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)